To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Accelrys (NASDAQ: ACCL) - Accelrys is the leader in Scientific Business Intelligence and Innovation that accelerates the discovery and development of novel therapeutics and materials. Accelrys develops and commercializes Scientific Business Intelligence software and solutions for the integration, mining, analysis, modeling, simulation, management and interactive reporting of scientific data. It provides solutions and products to Life Sciences and Material Sciences Industries, Government, and Academia worldwide.
Additional recommended knowledge
Innovation at Accelrys goes beyond its people and software. Accelrys manages the Nanotechnology Consortium that has delivered a range of cutting-edge software tools to meet the challenges of rational nanodesign.Accelrys has also created a SIG to develop the first ever biological registration system. The system is designed to capture IP for the biological entity and allow the users to uniquely identify each testable entity. Accelrys runs several SIGs focusing on cross-cutting science, automation, and parameter generation. Some activities include development of new research strategies, generation of molecular property data, and scientific validation. These innovations leverage the company's Scientific Business Intelligence, Modeling & Simulation, Cheminformatics, and Bioinformatics technologies.
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Accelrys". A list of authors is available in Wikipedia.|